Correction to: Genotoxic Effects of New Azoloazine Derivatives with Antitumor Activity in MCF-7 Tumor Cell Culture (Pharmaceutical Chemistry Journal, (2023), 57, 6, (822-827), 10.1007/s11094-023-02955-5)

Al-Humairi, A. H.; Speranskiy, D. L.; Rybalkina, O. Y.; Sadchikova, E. V.; Buldakov, M. A.; Frolova, A. A.; Cherdyntseva, N. V.; Udut, V. V.

doi:10.1007/s11094-024-03111-3

Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс: http://elar.urfu.ru/handle/10995/141484

Полная запись метаданных

Поле DC	Значение	Язык
dc.contributor.author	Al-Humairi, A. H.	en
dc.contributor.author	Speranskiy, D. L.	en
dc.contributor.author	Rybalkina, O. Y.	en
dc.contributor.author	Sadchikova, E. V.	en
dc.contributor.author	Buldakov, M. A.	en
dc.contributor.author	Frolova, A. A.	en
dc.contributor.author	Cherdyntseva, N. V.	en
dc.contributor.author	Udut, V. V.	en
dc.date.accessioned	2025-02-25T10:47:04Z	-
dc.date.available	2025-02-25T10:47:04Z	-
dc.date.issued	2024	-
dc.identifier.citation	Al-Humairi, A. H., Speranskiy, D. L., Rybalkina, O. Y., Sadchikova, E. V., Buldakov, M. A., Frolova, A. A., Cherdyntseva, N. V., & Udut, V. V. (2024). Correction to: Genotoxic Effects of New Azoloazine Derivatives with Antitumor Activity in MCF-7 Tumor Cell Culture. Pharmaceutical Chemistry Journal, 57(12), 2019-2019. https://doi.org/10.1007/s11094-024-03111-3	apa_pure
dc.identifier.issn	0091-150X	-
dc.identifier.issn	1573-9031	-
dc.identifier.other	Final	2
dc.identifier.other	All Open Access; Hybrid Gold Open Access	3
dc.identifier.other	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190672273&doi=10.1007%2fs11094-024-03111-3&partnerID=40&md5=93a597061a2db1bb3e501072bb8bdf1c	1
dc.identifier.other	https://link.springer.com/content/pdf/10.1007/s11094-024-03111-3.pdf	pdf
dc.identifier.uri	http://elar.urfu.ru/handle/10995/141484	-
dc.description.abstract	The 1st author’s name should read Ahmed Hamid Al-Humairi. © Springer Science+Business Media, LLC, part of Springer Nature 2024.	en
dc.format.mimetype	application/pdf	en
dc.language.iso	en	en
dc.publisher	Springer	en
dc.rights	info:eu-repo/semantics/openAccess	en
dc.rights	other-oa	other
dc.source	Pharmaceutical Chemistry Journal	2
dc.source	Pharmaceutical Chemistry Journal	en
dc.subject	ANTINEOPLASTIC ACTIVITY	en
dc.subject	CANCER INHIBITION	en
dc.subject	COMMERCIAL PHENOMENA	en
dc.subject	DRUG THERAPY	en
dc.subject	ERRATUM	en
dc.subject	GENOTOXICITY	en
dc.subject	HUMAN	en
dc.subject	MEDICINAL CHEMISTRY	en
dc.subject	TUMOR CELL CULTURE	en
dc.title	Correction to: Genotoxic Effects of New Azoloazine Derivatives with Antitumor Activity in MCF-7 Tumor Cell Culture (Pharmaceutical Chemistry Journal, (2023), 57, 6, (822-827), 10.1007/s11094-023-02955-5)	en
dc.type	Article	en
dc.type	info:eu-repo/semantics/article	en
dc.type	info:eu-repo/semantics/publishedVersion	en
dc.identifier.rsi	66598623	-
dc.identifier.doi	10.1007/s11094-024-03111-3	-
dc.identifier.scopus	85190672273	-
local.contributor.employee	Al-Humairi A.H., Volgograd State Medical University, Ministry of Health of Russia, 1 Pavshikh Bortsov Sq., Volgograd, 400131, Russian Federation, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Russian Academy of Sciences, 3 Prosp. Lenina, Tomsk, 634028, Russian Federation	en
local.contributor.employee	Speranskiy D.L., Volgograd State Medical University, Ministry of Health of Russia, 1 Pavshikh Bortsov Sq., Volgograd, 400131, Russian Federation	en
local.contributor.employee	Rybalkina O.Y., Goldberg Research Institute of Pharmacology and Regenerative Medicine, Russian Academy of Sciences, 3 Prosp. Lenina, Tomsk, 634028, Russian Federation	en
local.contributor.employee	Sadchikova E.V., Yeltsin Ural Federal University, 19 Mira St., Ekaterinburg, 620002, Russian Federation	en
local.contributor.employee	Buldakov M.A., Research Institute of Oncology, Russian Academy of Sciences, 5 Kooperativnyi Pereulok, Tomsk, 634009, Russian Federation	en
local.contributor.employee	Frolova A.A., Research Institute of Oncology, Russian Academy of Sciences, 5 Kooperativnyi Pereulok, Tomsk, 634009, Russian Federation	en
local.contributor.employee	Cherdyntseva N.V., Research Institute of Oncology, Russian Academy of Sciences, 5 Kooperativnyi Pereulok, Tomsk, 634009, Russian Federation	en
local.contributor.employee	Udut V.V., Goldberg Research Institute of Pharmacology and Regenerative Medicine, Russian Academy of Sciences, 3 Prosp. Lenina, Tomsk, 634028, Russian Federation	en
local.description.firstpage	2019
local.issue	12	-
local.volume	57	-
dc.identifier.wos	001204368800003	-
local.contributor.department	Volgograd State Medical University, Ministry of Health of Russia, 1 Pavshikh Bortsov Sq., Volgograd, 400131, Russian Federation	en
local.contributor.department	Goldberg Research Institute of Pharmacology and Regenerative Medicine, Russian Academy of Sciences, 3 Prosp. Lenina, Tomsk, 634028, Russian Federation	en
local.contributor.department	Yeltsin Ural Federal University, 19 Mira St., Ekaterinburg, 620002, Russian Federation	en
local.contributor.department	Research Institute of Oncology, Russian Academy of Sciences, 5 Kooperativnyi Pereulok, Tomsk, 634009, Russian Federation	en
local.identifier.pure	56644119	-
local.identifier.eid	2-s2.0-85190672273	-
local.identifier.wos	WOS:001204368800003	-
Располагается в коллекциях:	Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Файлы этого ресурса:

Файл	Описание	Размер	Формат
2-s2.0-85190672273.pdf		46,89 kB	Adobe PDF	Просмотреть/Открыть

Показать базовое описание ресурса Статистика

Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.